









Markets
/
Stocks
/
nasdaq-idya
/

IDEAYA Biosciences Inc

IDYA

View Detailed Chart

24.500USD

-0.330-1.33%

Close 07/25, 16:00（ET）Quotes delayed by 15 min

2.15BMarket Cap

LossP/E TTM



IDEAYA Biosciences Inc

24.500

-0.330-1.33%

Overview Company Financials

Financials

Intraday

30m

Today

-1.33%

5 Days

+13.48%

1 Month

+9.91%

6 Months

+3.73%

Year to Date

-4.67%

1 Year

-42.20%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 16 analysts

BUY

Current Rating

43.545

Target Price

77.74%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

IDEAYA Biosciences Inc

IDYA

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(1)

Neutral(1)

Buy(10)

Indicators

Sell(1)

Neutral(1)

Buy(4)

Indicators

Value

Direction

MACD(12,26,9)

0.426

Buy

RSI(14)

65.655

Neutral

STOCH(KDJ)(9,3,3)

74.127

Buy

ATR(14)

1.051

High Vlolatility

CCI(14)

193.424

Buy

Williams %R

24.074

Buy

TRIX(12,20)

0.274

Sell

StochRSI(14)

83.375

Overbought

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

23.358

Buy

MA10

22.663

Buy

MA20

22.251

Buy

MA50

21.268

Buy

MA100

19.576

Buy

MA200

22.804

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

IDEAYA Biosciences, Inc. is a precision medicine oncology company. The Company is engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its lead product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 / GSK959 (Werner Helicase), IDE161 (PARG), and IDE705 / GSK101 (Pol Theta Helicase). IDE196, a small-molecule protein kinase C (PKC) inhibitor, in combination with crizotinib, an investigational cMET inhibitor. IDE397 is its small-molecule methionine adenosyltransferase 2a (MAT2A) inhibitor. IDE275 (GSK959) Werner Helicase (WRN) inhibitor for patients having tumors with MSI-High. IDE161 (PARG) is a small-molecule poly (ADP-ribose) glycohydrolase, or PARG, inhibitor. IDE705 is a small-molecule inhibitor of Pol Theta Helicase, in combination with niraparib, the GSK small-molecule inhibitor of poly-(ADP-ribose) polymerase (PARP).

Ticker SymbolIDYA

CompanyIDEAYA Biosciences Inc

CEOMr. Yujiro S. Hata

Websitehttps://www.ideayabio.com/